Login Register

19 May 2015

Not a Dry Eye in the House? MSD Looks Closer to Prevent Canine Vision Loss

MILTON KEYNES, UK, May 2015 – MSD Animal Health (known as Merck Animal Health in the United States and Canada) is launching a new campaign that veterinary practices can get involved in this summer. ‘Take a closer look’ encourages dog owners to have their pet checked for dry eye (keratoconjunctivitis sicca). The condition causes progressive loss of vision unless detected and treated early; often this is before the pet owner even realises there is a problem. Practices can register to take part for free at www.ukvetsonline.co.ukfrom 1st June and help prevent pets from suffering pain, discomfort and even blindness.

Around 1 in every 22 dogs suffer from dry eye which in most cases is caused by destruction of the glands that produce tears needed to lubricate the surface of the eye. In the early stages, the pet’s eye surface may look dull but in many cases clients observe no changes at all. The ‘look closer’ campaign encourages dog owners to complete an online risk assessment and download a voucher for a free Schirmer tear test, which is diagnostic for dry eye, to take to their local vet practice.

Practices benefit from the additional footfall as well as the opportunity to make an early diagnosis which is essential for more successful treatment of the condition. Registration gives practices access to a free online CPD update on dry eye, as well as free Schirmer tear tests and a host of support material. Participating practices will also be listed in the ‘vet finder’ area of the mypetonline website and will be given extra help in the form of client emails, texts and postcards to raise awareness in their local area. 

Informative videos will also be available explaining the condition and practices will be able to embed those in their websites and share the content on social media. There’s a fun quiz and prizes to win for pet owners visiting the dry eye pages on mypetonline. The summer campaign will open up to dog owners on 1st July and run right through to 31st August.

‘Take a closer look’ offers an exciting opportunity for practices to be proactive about identifying a condition that has a devastating impact on pets and their owners, with all the professional support that MSD can put behind a national awareness raising drive.

Zorica Agbaba, Optimmune® Marketing Manager says, “There can be few things more likely to bond a pet owner to a practice than the ability to save their pet’s sight. We know the vets and nurses are passionate about the health and welfare of pets under their care and there is nothing more demoralising than the patient being presented after the condition has already progressed. The ‘Take a closer look’ campaign seeks to drive pet owners into practices at an early stage to help vets and nurses do what they do best – make pets’ lives better.”

Practices are encouraged to register early from 1st June to make sure they have all the materials in place to take full advantage of this important campaign. Register for free at www.ukvetsonline.co.uk

About MSD Animal Health

Today's MSD is a global healthcare leader working to help the world be well. MSD Animal Health, known as Merck Animal Health in the United States and Canada, is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals™, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com or connect with us on LinkedIn.

MSD forward-Looking Statement

This presentation includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of MSD’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; MSD’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of MSD’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

MSD undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in MSD’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

Optimmune® contains 0.2% ciclosporin.  Legal Category POM-V.

Please see product datasheet for further details.

For further information contact MSD Animal Health, Walton Manor, Walton, Milton Keynes, MK7 7AJ or visit www.msd-animal-health.co.uk

Use medicines responsibly.